![Lauren Rose Musto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lauren Rose Musto
Public Communications Contact chez CODEXIS, INC.
Postes actifs de Lauren Rose Musto
Sociétés | Poste | Début | Fin |
---|---|---|---|
CODEXIS, INC. | Public Communications Contact | 01/02/2023 | - |
Historique de carrière de Lauren Rose Musto
Anciens postes connus de Lauren Rose Musto
Sociétés | Poste | Début | Fin |
---|---|---|---|
SIERRA ONCOLOGY, INC. | Public Communications Contact | 01/09/2021 | 01/07/2022 |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Public Communications Contact | 2 |
Sectorielle
Health Technology | 2 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CODEXIS, INC. | Process Industries |
Entreprise privées | 1 |
---|---|
Sierra Oncology, Inc.
![]() Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
- Bourse
- Insiders
- Lauren Rose Musto
- Expérience